Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(301096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

301096 Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

Closed 12-12 15:00:00

54.00

+0.80

+1.50%

High55.09	Low53.03	Vol2.23M
Open53.32	D1 Closing53.20	Amplitude3.87%
Mkt Cap5.89B	Tradable Cap4.47B	Total Shares109.00M
T/O120.00M	T/O Rate2.69%	Tradable Shares82.79M
P/B2.25	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"301096","market":"SZ","secType":"STK","nameCN":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.","latestPrice":54,"timestamp":1765523037000,"preClose":53.2,"halted":0,"volume":2227100,"delay":0,"changeRate":0.015,"floatShares":82787200,"shares":109000000,"eps":-1.7237,"marketStatus":"Closed","change":0.8,"latestTime":"12-12 15:00:00","open":53.32,"high":55.09,"low":53.03,"amount":120000000,"amplitude":0.0387,"askPrice":54.22,"askSize":11,"bidPrice":54,"bidSize":237,"shortable":0,"etf":0,"ttmEps":-1.7237,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":53.2,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":58.52,"lowLimit":47.88,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":109228284,"isCdr":false,"pbRate":2.25,"roa":"--","roe":"0.24%","epsLYR":-0.49,"committee":0.057199,"marketValue":5898000000,"turnoverRate":0.0269,"status":0,"floatMarketCap":4471000000},"requestUrl":"/m/hq/s/301096/wiki","defaultTab":"wiki","newsList":[{"id":"1199628935","title":"Hangzhou Bio-Sincerity Pharma-Tech (301096.SZ) Receives Clinical Trial Approval for Innovative Drug BIOS-0625 Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1199628935","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199628935?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:42","pubTimestamp":1762519331,"startTime":"0","endTime":"0","summary":"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) announced that its self-developed innovative drug, BIOS-0625 tablets, has received clinical trial approval from the National Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","BK1161","301096","06978","BK0216"],"gpt_icon":0},{"id":"1156837411","title":"Hangzhou Bio-Sincerity Pharma-Tech Drops 9.03%, IPO in 2021 Peaked with 1.2 Billion Yuan Overfunding","url":"https://stock-news.laohu8.com/highlight/detail?id=1156837411","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156837411?lang=en_us&edition=fundamental","pubTime":"2025-11-05 17:20","pubTimestamp":1762334445,"startTime":"0","endTime":"0","summary":"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) closed at 55.99 yuan today, down 9.03%. The stock is currently trading below its IPO price. The company listed on the Shenzhen Stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301096","BK0216"],"gpt_icon":0},{"id":"1131739700","title":"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) Reports Q3 Results with Net Profit Decline of 95.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131739700","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131739700?lang=en_us&edition=fundamental","pubTime":"2025-10-24 21:00","pubTimestamp":1761310819,"startTime":"0","endTime":"0","summary":"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) has released its Q3 report for 2025. The company reported a revenue of 510 million yuan for the first three quarters, marking a year-on-year...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301096","BK0216"],"gpt_icon":0},{"id":"1165755739","title":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (301096.SZ): Innovative Drug BIOS-0623-Z4 Tablets Receives Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1165755739","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165755739?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:11","pubTimestamp":1759137091,"startTime":"0","endTime":"0","summary":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (301096.SZ) announced that the company has recently received notification that its independently developed innovative drug BIOS-0623-Z4 tablets has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","BK1574","301096","159992","BK0216"],"gpt_icon":0},{"id":"1130269964","title":"Hong Kong Stocks Movement | XTALPI (02228) Surges Over 8% Again on AI Drug Development Partnership with Hangzhou Bio-Sincerity and Strategic Talks with China Merchants Group","url":"https://stock-news.laohu8.com/highlight/detail?id=1130269964","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130269964?lang=en_us&edition=fundamental","pubTime":"2025-09-29 10:52","pubTimestamp":1759114345,"startTime":"0","endTime":"0","summary":"XTALPI (02228) surged over 8% again, closing up 6.66% at HK$12.97 with trading volume reaching HK$1.223 billion as of press time. On the news front, XTALPI recently announced the signing of a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","07226","BK1141","301096","BK1617","BK0216","BK4614","YANG","02228"],"gpt_icon":1},{"id":"1192765960","title":"Hong Kong Stocks Movement | XTALPI (02228) Surged Nearly 7% in Morning Trading as Company Signs Cooperation Agreement with Hangzhou Bio-Sincerity Pharma-Tech for Joint AI Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1192765960","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192765960?lang=en_us&edition=fundamental","pubTime":"2025-09-25 09:46","pubTimestamp":1758764787,"startTime":"0","endTime":"0","summary":"XTALPI (02228) rose nearly 7% during morning trading, with its stock price doubling since early August. As of press time, the stock was up 5.55% to HK$12.37, with a turnover of HK$448 million. On the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02228","BK0216","HSCEI","BK1617","BK4614","07226","YANG","301096"],"gpt_icon":1},{"id":"1127117941","title":"Hangzhou Bio-Sincerity Pharma-Tech (301096.SZ) Subsidiary Hangzhou Mipeng to Invest 15 Million Yuan in Partnership Enterprise, Focusing on Biomedicine and Hard Technology Strategic Emerging Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=1127117941","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127117941?lang=en_us&edition=fundamental","pubTime":"2025-09-22 18:46","pubTimestamp":1758537998,"startTime":"0","endTime":"0","summary":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (301096.SZ) announced that its controlled entity, Hangzhou Mipeng Enterprise Management Partnership (Limited Partnership) (\"Hangzhou Mipeng\"), plans to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","161726","301096","399441"],"gpt_icon":0},{"id":"1110356430","title":"September 11 Holdings Update Summary: Hangzhou Bio-Sincerity Pharma-Tech Increases Position While 26 Stocks Including Shanghai New Centurion Network Show Reductions","url":"https://stock-news.laohu8.com/highlight/detail?id=1110356430","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110356430?lang=en_us&edition=fundamental","pubTime":"2025-09-11 22:11","pubTimestamp":1757599908,"startTime":"0","endTime":"0","summary":"According to compiled data, on September 11, Hangzhou Bio-Sincerity Pharma-Tech disclosed an increase in holdings after market close. Meanwhile, 26 A-share listed companies announced reductions in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","BK0231","301096","605398"],"gpt_icon":0},{"id":"1179756550","title":"Hangzhou Bio-Sincerity Pharma-Tech Records Single Block Trade on August 21 with Total Value of 16.445 Million Yuan at 0.00% Premium","url":"https://stock-news.laohu8.com/highlight/detail?id=1179756550","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179756550?lang=en_us&edition=fundamental","pubTime":"2025-08-21 17:21","pubTimestamp":1755768114,"startTime":"0","endTime":"0","summary":"On August 21, Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. closed up 1.79% at 57.48 yuan per share, recording one block trade with a total volume of 286,100 shares and transaction value of 16.445...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","301096"],"gpt_icon":0},{"id":"1113392056","title":"BaiCheng Pharma (301096.SZ) Forecasts H1 Net Profit of RMB 0-6 Million, Plunging 95.53%-100% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1113392056","media":"Stock Track","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113392056?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:58","pubTimestamp":1752584305,"startTime":"0","endTime":"0","summary":"BaiCheng Medicine Technology Co., Ltd. (301096.SZ) has released its preliminary financial estimates for the first half of 2025, projecting a stark downturn in profitability. The company anticipates...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["301096","BK0216"],"gpt_icon":0},{"id":"1134394566","title":"Baicheng Medicine (301096.SZ) Forecasts H1 Net Profit Plunge to 0-6 Million Yuan, Down 95.53%-100%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134394566","media":"Stock Track","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134394566?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:45","pubTimestamp":1752579958,"startTime":"0","endTime":"0","summary":"Baicheng Medicine (301096.SZ) has disclosed its performance forecast for the first half of 2025. The company anticipates net profit attributable to shareholders will plummet to between 0 and 6...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BK0216","301096"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-12-20","address":"浙江省杭州市临平区临平街道绿洲路159号","stockEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":-0.0103},{"period":"3month","weight":-0.1332},{"period":"6month","weight":0.2157},{"period":"1year","weight":0.273},{"period":"ytd","weight":0.4233}],"companyName":"杭州百诚医药科技股份有限公司","boardCode":"AI0073","perCapita":"8212股","boardName":"研究和试验发展","registeredCapital":"10922万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　杭州百诚医药科技股份有限公司的主营业务是为各类制药企业、医药研发投资企业提供：医药技术受托研发服务（CRO业务）、研发技术成果转化服务、定制研发生产服务（CDMO）。公司的主要产品是临床前药学研究、研发技术成果转化、临床服务、CDMO、权益分成及其他。","serverTime":1765728925913,"listedPrice":79.6,"stockholders":"10081人(较上一季度减少15.05%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(301096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(301096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.,301096,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票老虎,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票老虎国际,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.行情,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票行情,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股价,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股市,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票价格,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票交易,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票购买,Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(301096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(301096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction